{"id":5781,"date":"2025-07-28T13:48:29","date_gmt":"2025-07-28T10:18:29","guid":{"rendered":"https:\/\/barkathpg.com\/?p=5781"},"modified":"2025-07-28T13:48:29","modified_gmt":"2025-07-28T10:18:29","slug":"5781","status":"publish","type":"post","link":"https:\/\/barkathpg.com\/en\/5781\/","title":{"rendered":""},"content":{"rendered":"<p dir=\"ltr\"><strong>Barekat Health &amp; Pharmaceutical Group:<\/strong> Saman Darou 8 Co., a knowledge-based enterprise under Barekat Holding, has successfully obtained the official marketing authorization for its recombinant coagulation Factor VIII product, \u201cSafacto,\u201d in Sri Lanka.<\/p>\n<p dir=\"ltr\">The certification\u2014issued for both 250 IU and 500 IU dosage forms\u2014is valid for a period of two years and represents formal approval for importation, marketing, and clinical use of Safacto in the Sri Lankan pharmaceutical market.<\/p>\n<p dir=\"ltr\"><strong>Safacto: A National Innovation with Global Standards<\/strong><\/p>\n<p dir=\"ltr\">Safacto, a recombinant Factor VIII therapy indicated for Hemophilia A, is manufactured using advanced biotechnological methods at Saman Darou 8, with full reliance on domestic expertise and innovation.<\/p>\n<p dir=\"ltr\">Having long been approved and distributed within Iran\u2019s healthcare system, this international registration marks a new milestone\u2014recognition of Safacto\u2019s quality, safety, and efficacy in compliance with the rigorous standards set forth by global regulatory authorities, including Sri Lanka\u2019s National Medicines Regulatory Authority (NMRA).<\/p>\n<p dir=\"ltr\"><strong>Strategic Advancement in Export Market Development<\/strong><\/p>\n<p dir=\"ltr\">The formal entry of Safacto into the Sri Lankan market signifies Saman Darou 8 first impactful step in international pharmaceutical export. This achievement is the result of months of coordinated efforts between scientific, regulatory, commercial, and export teams\u2014and it highlights the company\u2019s strong potential to expand into global markets.<\/p>\n<p dir=\"ltr\">Given the demand in regional and emerging markets for high-quality, cost-effective treatments for rare and chronic diseases, this registration paves the way for broader commercial engagement across Asia and beyond.<\/p>\n<p dir=\"ltr\"><strong>Synergy within Barekat Pharmaceutical Group<\/strong><\/p>\n<p dir=\"ltr\">This important milestone was made possible through the strategic vision and active support of the Barekat Health and Pharmaceutical Group. Barekat has consistently championed domestic innovation, export development, and public health advancement, enabling its subsidiaries to grow beyond borders.<\/p>\n<p dir=\"ltr\"><strong>A Bright Horizon for Internationalization of Saman Darou<\/strong><\/p>\n<p dir=\"ltr\">The registration of Safacto in Sri Lanka opens the door for further international submissions across Southeast Asia, Africa, and Latin America. In line with its strategic roadmap, Saman Darou 8 is actively preparing for the registration and export of additional recombinant and biologic products to targeted global markets.<\/p>\n<p dir=\"ltr\"><strong>Acknowledgment &amp; Vision Forward<\/strong><\/p>\n<p dir=\"ltr\">Saman Darou 8 expresses its sincere appreciation to the scientific, commercial, regulatory, and international teams whose dedication made this success possible, as well as to the leadership of the Barekat Holding for their guidance and continued support.<\/p>\n<p dir=\"ltr\">This is not merely an endpoint, but the beginning of a broader mission\u2014to elevate the global presence of Iranian pharmaceutical science and serve patients worldwide.<\/p>\n<div style='text-align:center' class='yasr-auto-insert-visitor'><\/div>","protected":false},"excerpt":{"rendered":"<p>Barekat Health &amp; Pharmaceutical Group: Saman Darou 8 Co., a knowledge-based enterprise under Barekat Holding, has successfully obtained the official marketing authorization for its recombinant coagulation Factor VIII product, \u201cSafacto,\u201d in Sri Lanka. The certification\u2014issued for both 250 IU and 500 IU dosage forms\u2014is valid for a period of two years and represents formal approval [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":5778,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"yasr_overall_rating":0,"yasr_post_is_review":"","yasr_auto_insert_disabled":"","yasr_review_type":"","footnotes":""},"categories":[24,27],"tags":[],"class_list":["post-5781","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-en","category-news-of-subsidiaries"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>- \u06af\u0631\u0648\u0647 \u0633\u0644\u0627\u0645\u062a \u0648 \u062f\u0627\u0631\u0648\u06cc\u06cc \u0628\u0631\u06a9\u062a<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/barkathpg.com\/en\/5781\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"- \u06af\u0631\u0648\u0647 \u0633\u0644\u0627\u0645\u062a \u0648 \u062f\u0627\u0631\u0648\u06cc\u06cc \u0628\u0631\u06a9\u062a\" \/>\n<meta property=\"og:description\" content=\"Barekat Health &amp; Pharmaceutical Group: Saman Darou 8 Co., a knowledge-based enterprise under Barekat Holding, has successfully obtained the official marketing authorization for its recombinant coagulation Factor VIII product, \u201cSafacto,\u201d in Sri Lanka. The certification\u2014issued for both 250 IU and 500 IU dosage forms\u2014is valid for a period of two years and represents formal approval [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/barkathpg.com\/en\/5781\/\" \/>\n<meta property=\"og:site_name\" content=\"\u06af\u0631\u0648\u0647 \u0633\u0644\u0627\u0645\u062a \u0648 \u062f\u0627\u0631\u0648\u06cc\u06cc \u0628\u0631\u06a9\u062a\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-28T10:18:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/barkathpg.com\/wp-content\/uploads\/2025\/07\/Untitled213.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"646\" \/>\n\t<meta property=\"og:image:height\" content=\"447\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin-barakat\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin-barakat\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/barkathpg.com\/en\/5781\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/barkathpg.com\/en\/5781\/\"},\"author\":{\"name\":\"admin-barakat\",\"@id\":\"https:\/\/barkathpg.com\/#\/schema\/person\/bcc8f949ef44f93ecc3b73bfaf1dd492\"},\"headline\":\"No title\",\"datePublished\":\"2025-07-28T10:18:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/barkathpg.com\/en\/5781\/\"},\"wordCount\":400,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/barkathpg.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/barkathpg.com\/en\/5781\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/barkathpg.com\/wp-content\/uploads\/2025\/07\/Untitled213.jpg\",\"articleSection\":[\"News\",\"News of subsidiaries\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/barkathpg.com\/en\/5781\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/barkathpg.com\/en\/5781\/\",\"url\":\"https:\/\/barkathpg.com\/en\/5781\/\",\"name\":\"- \u06af\u0631\u0648\u0647 \u0633\u0644\u0627\u0645\u062a \u0648 \u062f\u0627\u0631\u0648\u06cc\u06cc \u0628\u0631\u06a9\u062a\",\"isPartOf\":{\"@id\":\"https:\/\/barkathpg.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/barkathpg.com\/en\/5781\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/barkathpg.com\/en\/5781\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/barkathpg.com\/wp-content\/uploads\/2025\/07\/Untitled213.jpg\",\"datePublished\":\"2025-07-28T10:18:29+00:00\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/barkathpg.com\/en\/5781\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/barkathpg.com\/en\/5781\/#primaryimage\",\"url\":\"https:\/\/barkathpg.com\/wp-content\/uploads\/2025\/07\/Untitled213.jpg\",\"contentUrl\":\"https:\/\/barkathpg.com\/wp-content\/uploads\/2025\/07\/Untitled213.jpg\",\"width\":646,\"height\":447,\"caption\":\"\u062f\u0627\u0631\u0648\u06cc \u0633\u0627\u0641\u0627\u06a9\u062a\u0648\"},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/barkathpg.com\/#website\",\"url\":\"https:\/\/barkathpg.com\/\",\"name\":\"\u06af\u0631\u0648\u0647 \u0633\u0644\u0627\u0645\u062a \u0648 \u062f\u0627\u0631\u0648\u06cc\u06cc \u0628\u0631\u06a9\u062a\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/barkathpg.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/barkathpg.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/barkathpg.com\/#organization\",\"name\":\"\u06af\u0631\u0648\u0647 \u0633\u0644\u0627\u0645\u062a \u0648 \u062f\u0627\u0631\u0648\u06cc\u06cc \u0628\u0631\u06a9\u062a\",\"url\":\"https:\/\/barkathpg.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/barkathpg.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/barkathpg.com\/wp-content\/uploads\/2024\/10\/barakat.png\",\"contentUrl\":\"https:\/\/barkathpg.com\/wp-content\/uploads\/2024\/10\/barakat.png\",\"width\":363,\"height\":198,\"caption\":\"\u06af\u0631\u0648\u0647 \u0633\u0644\u0627\u0645\u062a \u0648 \u062f\u0627\u0631\u0648\u06cc\u06cc \u0628\u0631\u06a9\u062a\"},\"image\":{\"@id\":\"https:\/\/barkathpg.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/barkathpg.com\/#\/schema\/person\/bcc8f949ef44f93ecc3b73bfaf1dd492\",\"name\":\"admin-barakat\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/barkathpg.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/76eb030b98e7778e5aba48d357274751b5de2c7dae094669ef6d17a16cad14ec?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/76eb030b98e7778e5aba48d357274751b5de2c7dae094669ef6d17a16cad14ec?s=96&d=mm&r=g\",\"caption\":\"admin-barakat\"},\"sameAs\":[\"https:\/\/barkathpg.com\"],\"url\":\"https:\/\/barkathpg.com\/en\/author\/admin-barakat\/\"},false]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"- \u06af\u0631\u0648\u0647 \u0633\u0644\u0627\u0645\u062a \u0648 \u062f\u0627\u0631\u0648\u06cc\u06cc \u0628\u0631\u06a9\u062a","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/barkathpg.com\/en\/5781\/","og_locale":"en_US","og_type":"article","og_title":"- \u06af\u0631\u0648\u0647 \u0633\u0644\u0627\u0645\u062a \u0648 \u062f\u0627\u0631\u0648\u06cc\u06cc \u0628\u0631\u06a9\u062a","og_description":"Barekat Health &amp; Pharmaceutical Group: Saman Darou 8 Co., a knowledge-based enterprise under Barekat Holding, has successfully obtained the official marketing authorization for its recombinant coagulation Factor VIII product, \u201cSafacto,\u201d in Sri Lanka. The certification\u2014issued for both 250 IU and 500 IU dosage forms\u2014is valid for a period of two years and represents formal approval [&hellip;]","og_url":"https:\/\/barkathpg.com\/en\/5781\/","og_site_name":"\u06af\u0631\u0648\u0647 \u0633\u0644\u0627\u0645\u062a \u0648 \u062f\u0627\u0631\u0648\u06cc\u06cc \u0628\u0631\u06a9\u062a","article_published_time":"2025-07-28T10:18:29+00:00","og_image":[{"width":646,"height":447,"url":"https:\/\/barkathpg.com\/wp-content\/uploads\/2025\/07\/Untitled213.jpg","type":"image\/jpeg"}],"author":"admin-barakat","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin-barakat","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/barkathpg.com\/en\/5781\/#article","isPartOf":{"@id":"https:\/\/barkathpg.com\/en\/5781\/"},"author":{"name":"admin-barakat","@id":"https:\/\/barkathpg.com\/#\/schema\/person\/bcc8f949ef44f93ecc3b73bfaf1dd492"},"headline":"No title","datePublished":"2025-07-28T10:18:29+00:00","mainEntityOfPage":{"@id":"https:\/\/barkathpg.com\/en\/5781\/"},"wordCount":400,"commentCount":0,"publisher":{"@id":"https:\/\/barkathpg.com\/#organization"},"image":{"@id":"https:\/\/barkathpg.com\/en\/5781\/#primaryimage"},"thumbnailUrl":"https:\/\/barkathpg.com\/wp-content\/uploads\/2025\/07\/Untitled213.jpg","articleSection":["News","News of subsidiaries"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/barkathpg.com\/en\/5781\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/barkathpg.com\/en\/5781\/","url":"https:\/\/barkathpg.com\/en\/5781\/","name":"- \u06af\u0631\u0648\u0647 \u0633\u0644\u0627\u0645\u062a \u0648 \u062f\u0627\u0631\u0648\u06cc\u06cc \u0628\u0631\u06a9\u062a","isPartOf":{"@id":"https:\/\/barkathpg.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/barkathpg.com\/en\/5781\/#primaryimage"},"image":{"@id":"https:\/\/barkathpg.com\/en\/5781\/#primaryimage"},"thumbnailUrl":"https:\/\/barkathpg.com\/wp-content\/uploads\/2025\/07\/Untitled213.jpg","datePublished":"2025-07-28T10:18:29+00:00","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/barkathpg.com\/en\/5781\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/barkathpg.com\/en\/5781\/#primaryimage","url":"https:\/\/barkathpg.com\/wp-content\/uploads\/2025\/07\/Untitled213.jpg","contentUrl":"https:\/\/barkathpg.com\/wp-content\/uploads\/2025\/07\/Untitled213.jpg","width":646,"height":447,"caption":"\u062f\u0627\u0631\u0648\u06cc \u0633\u0627\u0641\u0627\u06a9\u062a\u0648"},{"@type":"WebSite","@id":"https:\/\/barkathpg.com\/#website","url":"https:\/\/barkathpg.com\/","name":"\u06af\u0631\u0648\u0647 \u0633\u0644\u0627\u0645\u062a \u0648 \u062f\u0627\u0631\u0648\u06cc\u06cc \u0628\u0631\u06a9\u062a","description":"","publisher":{"@id":"https:\/\/barkathpg.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/barkathpg.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/barkathpg.com\/#organization","name":"\u06af\u0631\u0648\u0647 \u0633\u0644\u0627\u0645\u062a \u0648 \u062f\u0627\u0631\u0648\u06cc\u06cc \u0628\u0631\u06a9\u062a","url":"https:\/\/barkathpg.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/barkathpg.com\/#\/schema\/logo\/image\/","url":"https:\/\/barkathpg.com\/wp-content\/uploads\/2024\/10\/barakat.png","contentUrl":"https:\/\/barkathpg.com\/wp-content\/uploads\/2024\/10\/barakat.png","width":363,"height":198,"caption":"\u06af\u0631\u0648\u0647 \u0633\u0644\u0627\u0645\u062a \u0648 \u062f\u0627\u0631\u0648\u06cc\u06cc \u0628\u0631\u06a9\u062a"},"image":{"@id":"https:\/\/barkathpg.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/barkathpg.com\/#\/schema\/person\/bcc8f949ef44f93ecc3b73bfaf1dd492","name":"admin-barakat","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/barkathpg.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/76eb030b98e7778e5aba48d357274751b5de2c7dae094669ef6d17a16cad14ec?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/76eb030b98e7778e5aba48d357274751b5de2c7dae094669ef6d17a16cad14ec?s=96&d=mm&r=g","caption":"admin-barakat"},"sameAs":["https:\/\/barkathpg.com"],"url":"https:\/\/barkathpg.com\/en\/author\/admin-barakat\/"},false]}},"yasr_visitor_votes":{"stars_attributes":{"read_only":false,"span_bottom":false},"number_of_votes":0,"sum_votes":0},"_links":{"self":[{"href":"https:\/\/barkathpg.com\/en\/wp-json\/wp\/v2\/posts\/5781","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/barkathpg.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/barkathpg.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/barkathpg.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/barkathpg.com\/en\/wp-json\/wp\/v2\/comments?post=5781"}],"version-history":[{"count":1,"href":"https:\/\/barkathpg.com\/en\/wp-json\/wp\/v2\/posts\/5781\/revisions"}],"predecessor-version":[{"id":5782,"href":"https:\/\/barkathpg.com\/en\/wp-json\/wp\/v2\/posts\/5781\/revisions\/5782"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/barkathpg.com\/en\/wp-json\/wp\/v2\/media\/5778"}],"wp:attachment":[{"href":"https:\/\/barkathpg.com\/en\/wp-json\/wp\/v2\/media?parent=5781"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/barkathpg.com\/en\/wp-json\/wp\/v2\/categories?post=5781"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/barkathpg.com\/en\/wp-json\/wp\/v2\/tags?post=5781"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}